arrow
A

Abdul-Hamid Emwas

King Abdulaziz University
H指数:71
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Copper(I)–triphenylphosphine complexes with thiourea and related sulfur-donor ligands: physicochemical characterization, biomolecular interactions, and in vitro anticancer properties

铜(I)–三苯基膦配合物与硫脲及相关硫配体:物理化学表征、生物分子相互作用和体外抗肿瘤活性

2026-09-100
PRE
Atomically Precise Rigid Copper Nanocluster as an Air-Stable Photocatalyst for Three-Component Coupling Reactions

原子级精确刚性铜纳米簇作为空气稳定的用于三组分偶联反应的光催化剂

2026-08-280
PRE
Design, Synthesis, and Antiproliferative Efficacy of an Innovative Series of Triazino[5,6-b]indole Derivatives Targeting EGFR, CD1, Hsp90, PI3K, and ERK/AKT as Key Molecular Targets in Cancer Therapy

设计、合成及靶向EGFR、CD1、Hsp90、PI3K和ERK/AKT作为癌症治疗关键分子靶点的新型三氮唑[5,6-b]吲哚衍生物的抗增殖活性

2025-10-160
PRE
Targeted design, synthesis, molecular dynamics, ADME and in –vitro anticancer assessment of oxo-tetrahydro-pyrimidin-benzenesulfonamide hybrids as potential BRAFV600E inhibitors

靶向设计、合成、分子动力学、ADME及体外抗肿瘤评估:作为潜在BRAFv600E抑制剂的氧杂四氢嘧啶-苯磺酰胺杂化物

2025-10-080
OA
Design and synthesis of multitarget triazinoindole derivatives with potent antiproliferative activity: Targeting EGFR, SIRT1, MDM2, Hsp90, PI3K, p53, and caspase-9

多靶点三氮唑并吲哚衍生物的设计与合成:具有强抗增殖活性,靶向EGFR、SIRT1、MDM2、Hsp90、PI3K、p53和caspase-9

2025-09-050
PRE
Synthesis, Identification, and Characterization of a Novel 1,2,5-Selenadiazole Derivative as a Microtubule Targeting Agent That Overcomes Multidrug Resistance

一种新型1,2,5-硒二唑衍生物的合成、鉴定与表征:作为克服多药耐药性的微管靶向剂

2025-09-030
PRE
Exploring GPR120/FFAR4 pharmacology: Unveiling novel therapeutic avenues through molecular signaling pathways for Alzheimer's disease intervention

探索GPR120/FFAR4药理学:通过分子信号通路揭示阿尔茨海默病干预的新型治疗途径

2025-07-110
PREAI
Synthesis, bioactivity, and molecular docking of pyrazole bearing Schiff-bases as prospective dual alpha-amylase and alpha-glucosidase inhibitors with antioxidant activity

带有席夫碱的吡唑作为具有抗氧化活性的潜在双重 α-淀粉酶和 α-葡萄糖苷酶抑制剂的合成,生物活性和分子对接

2025-01-015
PRE